FGF21 also improves insulin resistance by acting directly on islet β-cells by increasing the number of insulin receptors, inhibiting glucolipotoxicity-induced apoptosis, increasing insulin secretion, and reducing α-cell glucagon secretion [51]. This evidence concerns the gene INS and Insulin resistance.